Literature DB >> 10129840

Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year)

A Gafni1, S Birch, A Mehrez.   

Abstract

This paper responds to Culyer and Wagstaff's (CW) and Buckingham's (B) arguments. We refute their claim about the equivalence of HYEs and QALYs; they fail to distinguish between choice under uncertainty and under certainty. CW assume that all individuals have a specific form of utility function, which yields their conclusion of equivalence. B's arguments confuse the measurement technique and the utility theory from which it stems; his argument about the normative superiority of the QALY construct is inconsistent with economic thinking. The HYE, by being compatible with the principles of economics, is superior to the QALY for economic evaluations of health care interventions.

Mesh:

Year:  1993        PMID: 10129840     DOI: 10.1016/0167-6296(93)90015-7

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  11 in total

1.  Efficient use of health care resources: the interaction between improved health and reduced health related income loss.

Authors:  Michael Hoel
Journal:  Int J Health Care Finance Econ       Date:  2002-11

2.  Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.

Authors:  G W Torrance; D Blaker; A Detsky; W Kennedy; F Schubert; D Menon; P Tugwell; R Konchak; E Hubbard; T Firestone
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

Review 3.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 4.  Preferences, needs and QALYs.

Authors:  J Cohen
Journal:  J Med Ethics       Date:  1996-10       Impact factor: 2.903

Review 5.  QALYs and mental health care.

Authors:  D Chisholm; A Healey; M Knapp
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-02       Impact factor: 4.328

6.  Alternatives to the QALY measure for economic evaluations.

Authors:  A Gafni
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

7.  Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.

Authors:  Ariel Beresniak; Antonieta Medina-Lara; Jean Paul Auray; Alain De Wever; Jean-Claude Praet; Rosanna Tarricone; Aleksandra Torbica; Danielle Dupont; Michel Lamure; Gerard Duru
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

Review 8.  The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation.

Authors:  J Brazier
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

Review 9.  Outcome measurement in economic evaluations of public health interventions: a role for the capability approach?

Authors:  Paula K Lorgelly; Kenny D Lawson; Elisabeth A L Fenwick; Andrew H Briggs
Journal:  Int J Environ Res Public Health       Date:  2010-05-06       Impact factor: 3.390

10.  Individualized cost-effectiveness analysis.

Authors:  John P A Ioannidis; Alan M Garber
Journal:  PLoS Med       Date:  2011-07-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.